Total Payments
$5,054
2024 Payments
$915.85
Companies
54
Transactions
188
Medicare Patients
2,856
Medicare Billing
$159,947
Payment Breakdown by Category
Food & Beverage$4,651 (92.0%)
Education$402.94 (8.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,651 | 183 | 92.0% |
| Education | $402.94 | 5 | 8.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Karyopharm Therapeutics Inc. | $326.58 | 3 | $0 (2023) |
| Takeda Pharmaceuticals U.S.A., Inc. | $294.21 | 7 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $283.59 | 5 | $0 (2024) |
| Eisai Inc. | $266.29 | 9 | $0 (2024) |
| PFIZER INC. | $258.68 | 15 | $0 (2024) |
| Exelixis Inc. | $240.65 | 10 | $0 (2024) |
| Celgene Corporation | $195.69 | 4 | $0 (2024) |
| GENZYME CORPORATION | $195.36 | 5 | $0 (2023) |
| Lilly USA, LLC | $194.11 | 8 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $180.55 | 5 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $915.85 | 42 | SEAGEN INC. ($99.95) |
| 2023 | $1,662 | 56 | Exelixis Inc. ($182.94) |
| 2022 | $933.92 | 38 | Karyopharm Therapeutics Inc. ($202.07) |
| 2021 | $1,542 | 52 | Eisai Inc. ($146.29) |
All Payment Transactions
188 individual payment records from CMS Open Payments — Page 1 of 8
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/11/2024 | Regeneron Healthcare Solutions, Inc. | LIBTAYO (Biological) | Food and Beverage | In-kind items and services | $19.55 | General |
| Category: ONCOLOGY | ||||||
| 12/04/2024 | Incyte Corporation | PEMAZYRE (Drug), JAKAFI | Food and Beverage | Cash or cash equivalent | $16.42 | General |
| Category: Hepatology (Liver, Pancreatic, Gall Bladder) | ||||||
| 11/20/2024 | Takeda Pharmaceuticals U.S.A., Inc. | NINLARO (Drug) | Food and Beverage | In-kind items and services | $19.30 | General |
| Category: ONCOLOGY | ||||||
| 11/07/2024 | Lilly USA, LLC | VERZENIO (Drug), JAYPIRCA | Food and Beverage | In-kind items and services | $26.69 | General |
| Category: Oncology | ||||||
| 11/06/2024 | Teleflex LLC | ARROW (Device) | Food and Beverage | In-kind items and services | $20.90 | General |
| Category: INTERVENTIONAL ACCESS | ||||||
| 11/04/2024 | AngioDynamics, Inc. | SOLERO (Device) | Food and Beverage | In-kind items and services | $15.57 | General |
| Category: OS | ||||||
| 10/30/2024 | Incyte Corporation | PEMAZYRE (Drug), MONJUVI | Food and Beverage | Cash or cash equivalent | $24.44 | General |
| Category: Hepatology (Liver, Pancreatic, Gall Bladder) | ||||||
| 10/23/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $28.30 | General |
| 10/09/2024 | Pharmacosmos Therapeutics Inc. | COSELA (Drug) | Food and Beverage | In-kind items and services | $15.27 | General |
| Category: HEMATOLOGY | ||||||
| 09/30/2024 | SEAGEN INC. | — | Education | In-kind items and services | $99.95 | General |
| 09/30/2024 | GlaxoSmithKline, LLC. | ZEJULA (Drug), JEMPERLI | Food and Beverage | In-kind items and services | $22.38 | General |
| Category: ONCOLOGY | ||||||
| 09/25/2024 | Celgene Corporation | REBLOZYL (Biological) | Food and Beverage | Cash or cash equivalent | $25.99 | General |
| Category: Hematology | ||||||
| 09/18/2024 | PFIZER INC. | ELREXFIO (Drug), ADCETRIS | Food and Beverage | In-kind items and services | $16.02 | General |
| Category: ONCOLOGY | ||||||
| 09/04/2024 | ADC Therapeutics America, Inc. | — | Food and Beverage | In-kind items and services | $13.84 | General |
| 08/26/2024 | Novartis Pharmaceuticals Corporation | LUTATHERA (Drug) | Food and Beverage | In-kind items and services | $26.25 | General |
| Category: Oncology | ||||||
| 08/21/2024 | GlaxoSmithKline, LLC. | OJJAARA (Drug) | Food and Beverage | In-kind items and services | $21.17 | General |
| Category: ONCOLOGY | ||||||
| 08/14/2024 | SHIELD THERAPEUTICS INC | ACCRUFER (Drug) | Food and Beverage | In-kind items and services | $18.15 | General |
| Category: Hematology | ||||||
| 08/07/2024 | Exelixis Inc. | CABOMETYX (Drug) | Food and Beverage | In-kind items and services | $14.56 | General |
| Category: Renal Cell Carcinoma (RCC) Hepatocellular Carcinoma (HCC) Differentiated Thyroid Cancer (DTC) | ||||||
| 08/05/2024 | PFIZER INC. | XTANDI (Drug), ORGOVYX, TALZENNA | Food and Beverage | In-kind items and services | $19.48 | General |
| Category: ONCOLOGY | ||||||
| 07/17/2024 | Eisai Inc. | Lenvima (Drug) | Food and Beverage | In-kind items and services | $34.50 | General |
| Category: Oncology | ||||||
| 07/09/2024 | ABBVIE INC. | VENCLEXTA (Drug) | Food and Beverage | In-kind items and services | $19.52 | General |
| Category: ONCOLOGY | ||||||
| 07/03/2024 | Novartis Pharmaceuticals Corporation | PLUVICTO (Drug) | Food and Beverage | In-kind items and services | $21.60 | General |
| Category: Oncology | ||||||
| 06/26/2024 | PFIZER INC. | BOSULIF (Drug), ELREXFIO, ADCETRIS | Food and Beverage | In-kind items and services | $14.55 | General |
| Category: METABOLIC DISEASE;ONCOLOGY | ||||||
| 06/13/2024 | Janssen Biotech, Inc. | TECVAYLI (Biological), TALVEY | Food and Beverage | In-kind items and services | $15.83 | General |
| Category: Oncology | ||||||
| 06/05/2024 | Lilly USA, LLC | VERZENIO (Drug), JAYPIRCA | Food and Beverage | In-kind items and services | $23.57 | General |
| Category: Oncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 31 | 1,364 | 1,768 | $382,491 | $72,911 |
| 2022 | 20 | 876 | 20,734 | $276,104 | $57,414 |
| 2021 | 8 | 376 | 553 | $82,667 | $16,904 |
| 2020 | 6 | 240 | 440 | $83,780 | $12,718 |
Total Patients
2,856
Total Services
23,495
Medicare Billing
$159,947
Procedure Codes
65
All Medicare Procedures & Services
65 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 36561 | Insertion of central venous tube with port (5 years or older) | Office | 2023 | 35 | 35 | $108,442 | $21,075 | 19.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 140 | 188 | $54,238 | $10,218 | 18.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 95 | 113 | $46,265 | $8,658 | 18.7% |
| 38222 | Biopsy and aspiration of bone marrow sample for diagnosis | Office | 2023 | 51 | 52 | $28,780 | $5,497 | 19.1% |
| 32555 | Aspiration of fluid from chest cavity using imaging guidance | Office | 2023 | 16 | 19 | $23,167 | $3,798 | 16.4% |
| 77001 | Fluoroscopic guidance for insertion or removal of central vein access device | Office | 2023 | 57 | 57 | $17,949 | $3,351 | 18.7% |
| 77012 | Review by radiologist of ct guidance for needle placement | Office | 2023 | 34 | 34 | $15,376 | $3,071 | 20.0% |
| 99152 | Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | Office | 2023 | 85 | 88 | $13,771 | $2,720 | 19.7% |
| 36590 | Removal of central venous tube with port or pump | Office | 2023 | 22 | 22 | $15,499 | $2,529 | 16.3% |
| 38505 | Needle biopsy or removal of surface lymph nodes | Office | 2023 | 16 | 16 | $8,966 | $1,729 | 19.3% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 122 | 216 | $5,875 | $1,637 | 27.9% |
| 96413 | Administration of chemotherapy into vein, 1 hour or less | Office | 2023 | 18 | 20 | $9,096 | $1,613 | 17.7% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | Office | 2023 | 26 | 28 | $5,556 | $1,042 | 18.8% |
| 80048 | Blood test, basic group of blood chemicals (calcium, total) | Office | 2023 | 84 | 107 | $3,168 | $887.03 | 28.0% |
| 76937 | Ultrasonic guidance for blood vessel access | Office | 2023 | 35 | 35 | $6,023 | $842.18 | 14.0% |
| 76942 | Ultrasonic guidance for needle placement | Office | 2023 | 20 | 20 | $5,174 | $706.04 | 13.6% |
| 80076 | Liver function blood test panel | Office | 2023 | 71 | 86 | $2,460 | $688.86 | 28.0% |
| 96367 | Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | Office | 2023 | 28 | 38 | $3,453 | $659.39 | 19.1% |
| 99153 | Use of a drug to induce depression of consciousness by physician performing a procedure, each additional 15 minutes | Office | 2023 | 46 | 54 | $1,796 | $413.95 | 23.1% |
| 82728 | Ferritin (blood protein) level | Office | 2023 | 23 | 27 | $1,288 | $360.72 | 28.0% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 25 | 35 | $1,579 | $315.35 | 20.0% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 15 | 26 | $760.25 | $218.40 | 28.7% |
| 96375 | Injection of additional new drug or substance into vein | Office | 2023 | 22 | 23 | $1,113 | $212.52 | 19.1% |
| 83550 | Iron binding capacity | Office | 2023 | 21 | 24 | $734.16 | $205.68 | 28.0% |
| 83540 | Iron level | Office | 2023 | 21 | 24 | $543.60 | $152.16 | 28.0% |
About Bethany Kelley
Bethany Kelley is a Family healthcare provider based in Germantown, Tennessee. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/01/2019. The National Provider Identifier (NPI) number assigned to this provider is 1093270241.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Bethany Kelley has received a total of $5,054 in payments from pharmaceutical and medical device companies, with $915.85 received in 2024. These payments were reported across 188 transactions from 54 companies. The most common payment nature is "Food and Beverage" ($4,651).
As a Medicare-enrolled provider, Kelley has provided services to 2,856 Medicare beneficiaries, totaling 23,495 services with total Medicare billing of $159,947. Data is available for 4 years (2020–2023), covering 65 distinct procedure/service records.
Ad
Practice Information
- Specialty Family
- Location Germantown, TN
- Active Since 02/01/2019
- Last Updated 02/22/2019
- Taxonomy Code 363LF0000X
- Entity Type Individual
- NPI Number 1093270241
Products in Payments
- XPOVIO (Drug) $326.58
- LIBTAYO (Biological) $299.61
- Lenvima (Drug) $266.29
- COSELA (Drug) $199.13
- XARELTO (Drug) $180.55
- BRUKINSA (Drug) $167.23
- CABOMETYX (Drug) $140.66
- OPDIVO (Biological) $120.25
- VERZENIO (Drug) $119.18
- NINLARO (Drug) $112.21
- Tavalisse (Drug) $112.03
- INQOVI (Drug) $105.36
- XTANDI (Drug) $91.62
- REBLOZYL (Biological) $84.37
- VENCLEXTA (Drug) $73.49
- Monoferric (Drug) $66.93
- KEYTRUDA (Biological) $65.21
- Epkinly (Drug) $62.81
- Kyprolis (Drug) $57.85
- OJJAARA (Drug) $55.52
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Doctors in Germantown
Chantil Jeffreys, Dnp, DNP
Family — Payments: $125,057
Family $125,057
Dr. Angela Ugwuanyi, Dnp, Np-C, DNP, NP-C
Family — Payments: $13,865
Family $13,865
Mrs. Kristen Page, Np, NP
Family — Payments: $11,984
Family $11,984
Ms. Elizabeth Phillips, Fnp, FNP
Family — Payments: $11,106
Family $11,106
Emily Hoffmann, Np, NP
Family — Payments: $10,047
Family $10,047
Mrs. Christy Thornhill, Np, NP
Family — Payments: $8,421
Family $8,421